Zinc in PDB 6a9o: Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis
Enzymatic activity of Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis
All present enzymatic activity of Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis:
1.15.1.1;
Protein crystallography data
The structure of Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis, PDB code: 6a9o
was solved by
R.Manjula,
B.Padmanabhan,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
20.00 /
2.50
|
Space group
|
C 2 2 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
164.367,
203.692,
144.211,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
16.3 /
23.7
|
Zinc Binding Sites:
The binding sites of Zinc atom in the Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis
(pdb code 6a9o). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 9 binding sites of Zinc where determined in the
Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis, PDB code: 6a9o:
Jump to Zinc binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
9;
Zinc binding site 1 out
of 9 in 6a9o
Go back to
Zinc Binding Sites List in 6a9o
Zinc binding site 1 out
of 9 in the Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn201
b:49.5
occ:1.00
|
ND1
|
A:HIS80
|
2.1
|
34.9
|
1.0
|
ND1
|
A:HIS63
|
2.1
|
42.0
|
1.0
|
OD1
|
A:ASP83
|
2.2
|
35.1
|
1.0
|
ND1
|
A:HIS71
|
2.2
|
39.3
|
1.0
|
CG
|
A:ASP83
|
2.9
|
36.9
|
1.0
|
CE1
|
A:HIS80
|
3.0
|
33.6
|
1.0
|
OD2
|
A:ASP83
|
3.0
|
36.9
|
1.0
|
CG
|
A:HIS80
|
3.0
|
38.9
|
1.0
|
CE1
|
A:HIS63
|
3.1
|
45.2
|
1.0
|
CE1
|
A:HIS71
|
3.1
|
37.0
|
1.0
|
CG
|
A:HIS63
|
3.1
|
41.8
|
1.0
|
CG
|
A:HIS71
|
3.3
|
35.5
|
1.0
|
CB
|
A:HIS80
|
3.4
|
38.0
|
1.0
|
CB
|
A:HIS63
|
3.4
|
32.9
|
1.0
|
CB
|
A:HIS71
|
3.6
|
36.2
|
1.0
|
CA
|
A:HIS71
|
3.9
|
37.2
|
1.0
|
O
|
A:LYS136
|
4.1
|
46.6
|
1.0
|
NE2
|
A:HIS80
|
4.1
|
37.8
|
1.0
|
CD2
|
A:HIS80
|
4.1
|
40.3
|
1.0
|
NE2
|
A:HIS63
|
4.2
|
44.0
|
1.0
|
CD2
|
A:HIS63
|
4.3
|
46.4
|
1.0
|
NE2
|
A:HIS71
|
4.3
|
38.0
|
1.0
|
CB
|
A:ASP83
|
4.4
|
35.1
|
1.0
|
CD2
|
A:HIS71
|
4.4
|
37.3
|
1.0
|
CA
|
A:HIS80
|
4.8
|
34.5
|
1.0
|
CA
|
A:ASP83
|
4.8
|
34.7
|
1.0
|
N
|
A:GLY72
|
4.8
|
37.0
|
1.0
|
N
|
A:HIS80
|
4.8
|
39.0
|
1.0
|
O
|
A:HOH325
|
4.8
|
40.2
|
1.0
|
N
|
A:HIS71
|
4.8
|
38.9
|
1.0
|
C
|
A:HIS71
|
4.9
|
38.7
|
1.0
|
N
|
A:ASP83
|
4.9
|
34.9
|
1.0
|
CA
|
A:HIS63
|
5.0
|
34.4
|
1.0
|
C
|
A:LYS136
|
5.0
|
41.4
|
1.0
|
|
Zinc binding site 2 out
of 9 in 6a9o
Go back to
Zinc Binding Sites List in 6a9o
Zinc binding site 2 out
of 9 in the Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn201
b:39.6
occ:1.00
|
ND1
|
B:HIS63
|
2.0
|
30.6
|
1.0
|
ND1
|
B:HIS80
|
2.0
|
30.3
|
1.0
|
OD1
|
B:ASP83
|
2.0
|
25.9
|
1.0
|
ND1
|
B:HIS71
|
2.2
|
28.4
|
1.0
|
CG
|
B:ASP83
|
2.9
|
27.5
|
1.0
|
CE1
|
B:HIS80
|
2.9
|
28.4
|
1.0
|
CE1
|
B:HIS63
|
2.9
|
29.0
|
1.0
|
CE1
|
B:HIS71
|
3.0
|
27.1
|
1.0
|
OD2
|
B:ASP83
|
3.0
|
30.4
|
1.0
|
CG
|
B:HIS63
|
3.1
|
31.2
|
1.0
|
CG
|
B:HIS80
|
3.1
|
30.5
|
1.0
|
CG
|
B:HIS71
|
3.2
|
28.7
|
1.0
|
CB
|
B:HIS63
|
3.5
|
29.0
|
1.0
|
CB
|
B:HIS80
|
3.5
|
28.8
|
1.0
|
CB
|
B:HIS71
|
3.6
|
25.6
|
1.0
|
O
|
B:LYS136
|
3.9
|
35.7
|
1.0
|
CA
|
B:HIS71
|
4.0
|
29.5
|
1.0
|
NE2
|
B:HIS80
|
4.0
|
31.8
|
1.0
|
NE2
|
B:HIS63
|
4.1
|
30.5
|
1.0
|
CD2
|
B:HIS80
|
4.1
|
29.9
|
1.0
|
CD2
|
B:HIS63
|
4.2
|
29.8
|
1.0
|
NE2
|
B:HIS71
|
4.2
|
27.6
|
1.0
|
CD2
|
B:HIS71
|
4.3
|
27.6
|
1.0
|
CB
|
B:ASP83
|
4.3
|
28.5
|
1.0
|
N
|
B:HIS80
|
4.7
|
30.6
|
1.0
|
O
|
B:HOH325
|
4.7
|
30.6
|
1.0
|
CA
|
B:HIS80
|
4.8
|
26.8
|
1.0
|
N
|
B:GLY72
|
4.8
|
26.7
|
1.0
|
CA
|
B:ASP83
|
4.8
|
28.6
|
1.0
|
C
|
B:LYS136
|
4.8
|
35.8
|
1.0
|
N
|
B:HIS71
|
4.9
|
31.2
|
1.0
|
CD2
|
B:HIS46
|
4.9
|
28.4
|
1.0
|
N
|
B:ASP83
|
4.9
|
29.6
|
1.0
|
C
|
B:HIS71
|
4.9
|
28.8
|
1.0
|
CA
|
B:HIS63
|
5.0
|
30.8
|
1.0
|
|
Zinc binding site 3 out
of 9 in 6a9o
Go back to
Zinc Binding Sites List in 6a9o
Zinc binding site 3 out
of 9 in the Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn201
b:49.2
occ:1.00
|
ND1
|
C:HIS80
|
2.1
|
44.5
|
1.0
|
OD1
|
C:ASP83
|
2.1
|
40.1
|
1.0
|
ND1
|
C:HIS71
|
2.3
|
42.7
|
1.0
|
ND1
|
C:HIS63
|
2.4
|
46.1
|
1.0
|
CG
|
C:ASP83
|
2.8
|
39.9
|
1.0
|
OD2
|
C:ASP83
|
2.8
|
37.6
|
1.0
|
CG
|
C:HIS80
|
3.0
|
45.5
|
1.0
|
CE1
|
C:HIS80
|
3.0
|
43.6
|
1.0
|
CG
|
C:HIS71
|
3.2
|
41.5
|
1.0
|
CE1
|
C:HIS71
|
3.3
|
42.0
|
1.0
|
CB
|
C:HIS80
|
3.3
|
39.7
|
1.0
|
CG
|
C:HIS63
|
3.3
|
40.8
|
1.0
|
CE1
|
C:HIS63
|
3.4
|
48.6
|
1.0
|
CB
|
C:HIS71
|
3.5
|
41.1
|
1.0
|
CB
|
C:HIS63
|
3.5
|
42.6
|
1.0
|
CA
|
C:HIS71
|
3.8
|
40.7
|
1.0
|
O
|
C:LYS136
|
3.8
|
54.2
|
1.0
|
CD2
|
C:HIS80
|
4.1
|
51.1
|
1.0
|
NE2
|
C:HIS80
|
4.1
|
54.8
|
1.0
|
CB
|
C:ASP83
|
4.2
|
34.9
|
1.0
|
NE2
|
C:HIS71
|
4.4
|
44.3
|
1.0
|
CD2
|
C:HIS71
|
4.4
|
44.4
|
1.0
|
CD2
|
C:HIS63
|
4.5
|
46.4
|
1.0
|
NE2
|
C:HIS63
|
4.5
|
48.2
|
1.0
|
CA
|
C:HIS80
|
4.5
|
39.6
|
1.0
|
N
|
C:HIS80
|
4.6
|
46.9
|
1.0
|
CA
|
C:ASP83
|
4.8
|
32.4
|
1.0
|
N
|
C:GLY72
|
4.8
|
43.9
|
1.0
|
C
|
C:LYS136
|
4.8
|
50.9
|
1.0
|
N
|
C:HIS71
|
4.8
|
43.0
|
1.0
|
C
|
C:HIS71
|
4.8
|
43.2
|
1.0
|
N
|
C:ASP83
|
4.9
|
37.7
|
1.0
|
|
Zinc binding site 4 out
of 9 in 6a9o
Go back to
Zinc Binding Sites List in 6a9o
Zinc binding site 4 out
of 9 in the Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn201
b:41.1
occ:1.00
|
OD1
|
D:ASP83
|
1.9
|
33.1
|
1.0
|
ND1
|
D:HIS63
|
2.2
|
31.5
|
1.0
|
ND1
|
D:HIS80
|
2.2
|
30.9
|
1.0
|
ND1
|
D:HIS71
|
2.2
|
31.8
|
1.0
|
CG
|
D:ASP83
|
2.7
|
30.1
|
1.0
|
OD2
|
D:ASP83
|
2.9
|
31.6
|
1.0
|
CE1
|
D:HIS80
|
3.0
|
27.8
|
1.0
|
CE1
|
D:HIS71
|
3.0
|
29.0
|
1.0
|
CE1
|
D:HIS63
|
3.1
|
27.4
|
1.0
|
CG
|
D:HIS63
|
3.2
|
33.8
|
1.0
|
CG
|
D:HIS80
|
3.2
|
30.0
|
1.0
|
CG
|
D:HIS71
|
3.2
|
30.1
|
1.0
|
CB
|
D:HIS63
|
3.5
|
31.3
|
1.0
|
CB
|
D:HIS80
|
3.6
|
30.1
|
1.0
|
CB
|
D:HIS71
|
3.6
|
28.4
|
1.0
|
O
|
D:LYS136
|
3.9
|
32.6
|
1.0
|
CA
|
D:HIS71
|
4.0
|
30.6
|
1.0
|
NE2
|
D:HIS80
|
4.1
|
31.9
|
1.0
|
CB
|
D:ASP83
|
4.2
|
30.8
|
1.0
|
NE2
|
D:HIS71
|
4.2
|
31.5
|
1.0
|
CD2
|
D:HIS80
|
4.2
|
32.6
|
1.0
|
NE2
|
D:HIS63
|
4.2
|
30.6
|
1.0
|
CD2
|
D:HIS63
|
4.3
|
36.0
|
1.0
|
CD2
|
D:HIS71
|
4.3
|
27.1
|
1.0
|
CA
|
D:ASP83
|
4.6
|
27.2
|
1.0
|
N
|
D:HIS80
|
4.8
|
30.1
|
1.0
|
CA
|
D:HIS80
|
4.8
|
31.0
|
1.0
|
N
|
D:GLY72
|
4.8
|
27.4
|
1.0
|
N
|
D:ASP83
|
4.9
|
27.3
|
1.0
|
C
|
D:LYS136
|
4.9
|
33.7
|
1.0
|
C
|
D:HIS71
|
5.0
|
29.4
|
1.0
|
N
|
D:HIS71
|
5.0
|
32.4
|
1.0
|
|
Zinc binding site 5 out
of 9 in 6a9o
Go back to
Zinc Binding Sites List in 6a9o
Zinc binding site 5 out
of 9 in the Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 5 of Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:Zn201
b:62.8
occ:1.00
|
ND1
|
E:HIS80
|
2.2
|
52.5
|
1.0
|
ND1
|
E:HIS63
|
2.3
|
43.2
|
1.0
|
OD1
|
E:ASP83
|
2.4
|
46.7
|
1.0
|
ND1
|
E:HIS71
|
2.5
|
60.5
|
1.0
|
OD2
|
E:ASP83
|
2.9
|
55.3
|
1.0
|
CG
|
E:ASP83
|
3.0
|
53.6
|
1.0
|
CE1
|
E:HIS80
|
3.1
|
50.8
|
1.0
|
CG
|
E:HIS63
|
3.1
|
42.5
|
1.0
|
CG
|
E:HIS80
|
3.2
|
59.0
|
1.0
|
CE1
|
E:HIS63
|
3.3
|
50.5
|
1.0
|
CB
|
E:HIS63
|
3.3
|
36.7
|
1.0
|
CE1
|
E:HIS71
|
3.4
|
65.0
|
1.0
|
CB
|
E:HIS80
|
3.5
|
45.4
|
1.0
|
CG
|
E:HIS71
|
3.6
|
67.8
|
1.0
|
CB
|
E:HIS71
|
3.9
|
61.8
|
1.0
|
CA
|
E:HIS71
|
4.1
|
62.3
|
1.0
|
O
|
E:LYS136
|
4.2
|
61.5
|
1.0
|
NE2
|
E:HIS80
|
4.2
|
62.9
|
1.0
|
CD2
|
E:HIS63
|
4.3
|
49.4
|
1.0
|
CD2
|
E:HIS80
|
4.3
|
62.0
|
1.0
|
NE2
|
E:HIS63
|
4.3
|
54.3
|
1.0
|
CB
|
E:ASP83
|
4.5
|
41.4
|
1.0
|
CD2
|
E:HIS46
|
4.5
|
45.9
|
1.0
|
NE2
|
E:HIS71
|
4.5
|
68.6
|
1.0
|
N
|
E:HIS80
|
4.6
|
44.4
|
1.0
|
CD2
|
E:HIS71
|
4.6
|
74.0
|
1.0
|
CA
|
E:HIS80
|
4.7
|
43.1
|
1.0
|
CA
|
E:HIS63
|
4.8
|
37.8
|
1.0
|
C
|
E:LYS136
|
5.0
|
64.7
|
1.0
|
N
|
E:GLY72
|
5.0
|
56.3
|
1.0
|
|
Zinc binding site 6 out
of 9 in 6a9o
Go back to
Zinc Binding Sites List in 6a9o
Zinc binding site 6 out
of 9 in the Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 6 of Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
F:Zn202
b:39.5
occ:1.00
|
OD1
|
F:ASP83
|
2.0
|
31.2
|
1.0
|
ND1
|
F:HIS63
|
2.1
|
33.2
|
1.0
|
ND1
|
F:HIS80
|
2.1
|
31.1
|
1.0
|
ND1
|
F:HIS71
|
2.2
|
25.3
|
1.0
|
CG
|
F:ASP83
|
2.8
|
33.9
|
1.0
|
CE1
|
F:HIS80
|
3.0
|
28.8
|
1.0
|
OD2
|
F:ASP83
|
3.0
|
39.2
|
1.0
|
CE1
|
F:HIS63
|
3.0
|
31.6
|
1.0
|
CE1
|
F:HIS71
|
3.0
|
26.9
|
1.0
|
CG
|
F:HIS80
|
3.1
|
28.2
|
1.0
|
CG
|
F:HIS63
|
3.1
|
33.4
|
1.0
|
CG
|
F:HIS71
|
3.3
|
26.1
|
1.0
|
CB
|
F:HIS80
|
3.5
|
25.9
|
1.0
|
CB
|
F:HIS63
|
3.5
|
32.8
|
1.0
|
CB
|
F:HIS71
|
3.8
|
27.3
|
1.0
|
O
|
F:LYS136
|
4.0
|
32.4
|
1.0
|
NE2
|
F:HIS80
|
4.1
|
29.7
|
1.0
|
CA
|
F:HIS71
|
4.1
|
29.3
|
1.0
|
CD2
|
F:HIS80
|
4.1
|
29.6
|
1.0
|
NE2
|
F:HIS63
|
4.1
|
31.1
|
1.0
|
NE2
|
F:HIS71
|
4.2
|
28.3
|
1.0
|
CB
|
F:ASP83
|
4.2
|
30.6
|
1.0
|
CD2
|
F:HIS63
|
4.2
|
32.2
|
1.0
|
CD2
|
F:HIS71
|
4.4
|
24.2
|
1.0
|
CA
|
F:ASP83
|
4.6
|
28.4
|
1.0
|
N
|
F:HIS80
|
4.8
|
31.9
|
1.0
|
CA
|
F:HIS80
|
4.8
|
28.5
|
1.0
|
N
|
F:ASP83
|
4.8
|
28.3
|
1.0
|
O
|
F:HOH383
|
4.8
|
34.6
|
1.0
|
CD2
|
F:HIS46
|
4.9
|
25.4
|
1.0
|
N
|
F:GLY72
|
4.9
|
26.3
|
1.0
|
C
|
F:LYS136
|
5.0
|
32.8
|
1.0
|
CA
|
F:HIS63
|
5.0
|
33.1
|
1.0
|
|
Zinc binding site 7 out
of 9 in 6a9o
Go back to
Zinc Binding Sites List in 6a9o
Zinc binding site 7 out
of 9 in the Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 7 of Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
H:Zn201
b:48.3
occ:1.00
|
OD1
|
H:ASP83
|
2.0
|
36.3
|
1.0
|
ND1
|
H:HIS80
|
2.1
|
45.3
|
1.0
|
ND1
|
H:HIS71
|
2.1
|
35.5
|
1.0
|
ND1
|
H:HIS63
|
2.2
|
37.0
|
1.0
|
CG
|
H:ASP83
|
2.7
|
39.3
|
1.0
|
OD2
|
H:ASP83
|
2.9
|
42.6
|
1.0
|
CE1
|
H:HIS80
|
2.9
|
37.5
|
1.0
|
CE1
|
H:HIS71
|
3.0
|
39.5
|
1.0
|
CG
|
H:HIS80
|
3.0
|
44.2
|
1.0
|
CG
|
H:HIS63
|
3.1
|
38.0
|
1.0
|
CG
|
H:HIS71
|
3.2
|
39.5
|
1.0
|
CE1
|
H:HIS63
|
3.3
|
35.8
|
1.0
|
CB
|
H:HIS63
|
3.3
|
36.0
|
1.0
|
CB
|
H:HIS80
|
3.5
|
39.8
|
1.0
|
CB
|
H:HIS71
|
3.5
|
36.2
|
1.0
|
CA
|
H:HIS71
|
3.8
|
41.0
|
1.0
|
NE2
|
H:HIS80
|
4.0
|
38.9
|
1.0
|
O
|
H:LYS136
|
4.0
|
38.9
|
1.0
|
CD2
|
H:HIS80
|
4.1
|
43.2
|
1.0
|
CB
|
H:ASP83
|
4.1
|
37.9
|
1.0
|
NE2
|
H:HIS71
|
4.2
|
39.2
|
1.0
|
CD2
|
H:HIS71
|
4.3
|
38.7
|
1.0
|
CD2
|
H:HIS63
|
4.3
|
36.9
|
1.0
|
NE2
|
H:HIS63
|
4.4
|
37.7
|
1.0
|
N
|
H:GLY72
|
4.6
|
40.2
|
1.0
|
CA
|
H:ASP83
|
4.6
|
33.3
|
1.0
|
N
|
H:ASP83
|
4.7
|
31.7
|
1.0
|
N
|
H:HIS80
|
4.7
|
38.8
|
1.0
|
CA
|
H:HIS80
|
4.7
|
34.1
|
1.0
|
C
|
H:HIS71
|
4.7
|
42.5
|
1.0
|
C
|
H:LYS136
|
4.9
|
39.4
|
1.0
|
CA
|
H:HIS63
|
4.9
|
37.2
|
1.0
|
N
|
H:HIS71
|
4.9
|
41.9
|
1.0
|
|
Zinc binding site 8 out
of 9 in 6a9o
Go back to
Zinc Binding Sites List in 6a9o
Zinc binding site 8 out
of 9 in the Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 8 of Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
I:Zn201
b:59.9
occ:1.00
|
ND1
|
I:HIS63
|
2.2
|
49.5
|
1.0
|
OD1
|
I:ASP83
|
2.3
|
59.4
|
1.0
|
ND1
|
I:HIS80
|
2.4
|
52.3
|
1.0
|
ND1
|
I:HIS71
|
2.6
|
65.2
|
1.0
|
OD2
|
I:ASP83
|
2.9
|
54.6
|
1.0
|
CG
|
I:ASP83
|
2.9
|
57.6
|
1.0
|
CG
|
I:HIS63
|
3.1
|
52.0
|
1.0
|
CE1
|
I:HIS71
|
3.1
|
70.1
|
1.0
|
CG
|
I:HIS80
|
3.2
|
52.5
|
1.0
|
CB
|
I:HIS63
|
3.2
|
46.5
|
1.0
|
CE1
|
I:HIS80
|
3.3
|
53.4
|
1.0
|
CE1
|
I:HIS63
|
3.3
|
54.6
|
1.0
|
CB
|
I:HIS80
|
3.5
|
47.7
|
1.0
|
CG
|
I:HIS71
|
3.8
|
65.9
|
1.0
|
O
|
I:LYS136
|
4.0
|
60.6
|
1.0
|
CD2
|
I:HIS63
|
4.3
|
53.4
|
1.0
|
CA
|
I:HIS71
|
4.3
|
63.1
|
1.0
|
CD2
|
I:HIS80
|
4.3
|
51.6
|
1.0
|
CB
|
I:ASP83
|
4.3
|
48.8
|
1.0
|
NE2
|
I:HIS80
|
4.3
|
53.6
|
1.0
|
CB
|
I:HIS71
|
4.3
|
58.9
|
1.0
|
NE2
|
I:HIS63
|
4.3
|
51.7
|
1.0
|
NE2
|
I:HIS71
|
4.4
|
67.7
|
1.0
|
O
|
I:HOH316
|
4.6
|
61.8
|
1.0
|
N
|
I:HIS80
|
4.7
|
54.5
|
1.0
|
CD2
|
I:HIS71
|
4.7
|
60.5
|
1.0
|
CA
|
I:HIS80
|
4.7
|
50.2
|
1.0
|
CA
|
I:ASP83
|
4.8
|
49.5
|
1.0
|
CA
|
I:HIS63
|
4.8
|
48.0
|
1.0
|
CD2
|
I:HIS46
|
4.8
|
50.5
|
1.0
|
N
|
I:GLY72
|
5.0
|
60.3
|
1.0
|
|
Zinc binding site 9 out
of 9 in 6a9o
Go back to
Zinc Binding Sites List in 6a9o
Zinc binding site 9 out
of 9 in the Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 9 of Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
J:Zn201
b:50.9
occ:1.00
|
OD1
|
J:ASP83
|
2.0
|
48.4
|
1.0
|
ND1
|
J:HIS71
|
2.1
|
38.1
|
1.0
|
ND1
|
J:HIS80
|
2.1
|
38.0
|
1.0
|
ND1
|
J:HIS63
|
2.2
|
42.6
|
1.0
|
CG
|
J:ASP83
|
2.8
|
43.2
|
1.0
|
CE1
|
J:HIS80
|
2.9
|
39.8
|
1.0
|
OD2
|
J:ASP83
|
2.9
|
41.7
|
1.0
|
CE1
|
J:HIS63
|
3.1
|
46.4
|
1.0
|
CG
|
J:HIS71
|
3.1
|
40.5
|
1.0
|
CE1
|
J:HIS71
|
3.1
|
37.1
|
1.0
|
CG
|
J:HIS80
|
3.1
|
38.8
|
1.0
|
CG
|
J:HIS63
|
3.2
|
45.8
|
1.0
|
CB
|
J:HIS71
|
3.4
|
42.6
|
1.0
|
CB
|
J:HIS63
|
3.5
|
48.7
|
1.0
|
CB
|
J:HIS80
|
3.6
|
42.1
|
1.0
|
O
|
J:LYS136
|
3.6
|
45.3
|
1.0
|
CA
|
J:HIS71
|
3.9
|
43.2
|
1.0
|
NE2
|
J:HIS80
|
4.0
|
37.7
|
1.0
|
CD2
|
J:HIS80
|
4.1
|
38.5
|
1.0
|
CB
|
J:ASP83
|
4.1
|
44.1
|
1.0
|
NE2
|
J:HIS71
|
4.2
|
47.9
|
1.0
|
CD2
|
J:HIS71
|
4.2
|
39.5
|
1.0
|
NE2
|
J:HIS63
|
4.2
|
42.5
|
1.0
|
CD2
|
J:HIS63
|
4.3
|
45.3
|
1.0
|
CA
|
J:ASP83
|
4.6
|
48.1
|
1.0
|
C
|
J:LYS136
|
4.7
|
50.5
|
1.0
|
N
|
J:ASP83
|
4.8
|
42.8
|
1.0
|
CA
|
J:HIS80
|
4.8
|
42.7
|
1.0
|
O
|
J:HOH334
|
4.8
|
44.3
|
1.0
|
N
|
J:HIS80
|
4.8
|
41.9
|
1.0
|
C
|
J:HIS71
|
4.8
|
45.3
|
1.0
|
N
|
J:GLY72
|
4.9
|
41.6
|
1.0
|
CD2
|
J:HIS46
|
4.9
|
43.6
|
1.0
|
|
Reference:
R.Manjula,
S.Unni,
G.S.A.Wright,
S.Bharath M M,
B.Padmanabhan.
Rational Discovery of A SOD1 Tryptophan Oxidation Inhibitor with Therapeutic Potential For Amyotrophic Lateral Sclerosis. J.Biomol.Struct.Dyn. V. 37 3936 2019.
ISSN: ESSN 1538-0254
PubMed: 30286701
DOI: 10.1080/07391102.2018.1531787
Page generated: Mon Oct 28 17:27:30 2024
|